The exact cause of GLP-1-related hair loss is unclear, but experts say it could be attributed to weight loss from the medication
Regulators increasingly expect explicit acknowledgment of such uncertainty and clear plans to resolve it through biomarker-driven early-phase studies, rather than relying solely on associative epidemiology
Phase 1: Foundation Weeks 1-12 Body adapts to medication
The closest approved alternative in terms of multi-receptor action is Mounjaro (tirzepatide), which targets both GLP-1 and GIP receptors
Theyre going on these medications to lose weight, to improve their diabetes, their sleep apnea, their heart failure all their obesity-related conditions, but not cancer. Wolver praised the thoroughness of Chiangs research, noting that it broke down analyses by factors such as GLP-1 type, including older versions of the drug that were approved more than a decade ago
If you take birth control pills by mouth, talk to your healthcare provider before you take Foundayo
